Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2024 results , with sales up 14.6% year on year to $2.62 billion. Its non-GAAP profit of $2.23 per share was 2.1% above ...

Context-based analysis can be done by manually drawing regions of interest. TMA can be analysed and also detected on imported files. Analysis profiles can be created and used for automated analysis.

Context-based analysis can be done by manually drawing regions of interest. TMA can be analysed and also detected on imported files. Analysis profiles can be created and used for automated analysis.

Ratings for Quest Diagnostics DGX were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Quest Diagnostics saw robust growth in earnings and revenue, surpassing expectations for Q4 2024. Overall, Quest had a successful quarter, driven by strategic acquisitions and advancements in its ...

Shares of Quest Diagnostics (NYSE:DGX) were up 6% in morning trading after the company raised its dividend and issued an earnings report and outlook that topped Street estimates. Quest (NYSE ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2024 results topping the market’s revenue expectations , with sales up 14.6% year on year to $2.62 billion. Its non-GAAP ...